New-ATE-Logo2019 (1)

 

Advanced CLD with S-CHOice®:

Higher Productivity with Transposase

Technology and Improved ADCC with S-AfuCHO™

Presenter:

12-12-2024-Samsung-ATE-HS-Cropped
Janet Lee
director, cell line development,
Samsung Biologics
 

Janet Lee is the director of cell line development at Samsung Biologics, bringing over 25 years of experience in biologics development. Janet specializes in cGMP drug substance manufacturing, with expertise spanning clinical production to commercial-scale operations of up to 15,000 liters. Her background includes cell culture, cell line development, technology transfer, and CMC strategy, along with extensive experience leading cross-functional teams. Janet’s work focuses on driving process optimization and applying scientific rigor to ensure the development and manufacturing of high-quality biologics.